المؤلفون: Huber R. M., Hansen K. H., Paz-Ares Rodriguez L., West H. L., Reckamp K. L., Leighl N. B., Tiseo M., Smit E. F., Kim D. -W., Gettinger S. N., Hochmair M. J., Kim S. -W., Langer C. J., Ahn M. -J., Kim E. S., Kerstein D., Groen H. J. M., Camidge D. R.

المساهمون: Huber, R. M., Hansen, K. H., Paz-Ares Rodriguez, L., West, H. L., Reckamp, K. L., Leighl, N. B., Tiseo, M., Smit, E. F., Kim, D. -W., Gettinger, S. N., Hochmair, M. J., Kim, S. -W., Langer, C. J., Ahn, M. -J., Kim, E. S., Kerstein, D., Groen, H. J. M., Camidge, D. R.

مصطلحات موضوعية: ALK tyrosine kinase receptor, Anaplastic lymphoma kinase, Brigatinib, Non–small cell lung cancer

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000516801100021; volume:15; issue:3; firstpage:404-415; lastpage:415; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11381/2872428Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078003185; https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

الإتاحة: https://doi.org/10.1016Test/j.jtho.2019.11.004
http://hdl.handle.net/11381/2872428Test
https://www.journals.elsevier.com/journal-of-thoracic-oncologyTest/

المؤلفون: Paz-Ares, L., Spira, A., Raben, D., Planchard, D., Cho, B. C., Özgüroğlu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Spigel, D., Senan, S., Langer, C. J., Perez, B. A., Boothman, A. M., Broadhurst, H., Wadsworth, C., Dennis, P. A., Antonia, S. J., Faivre-Finn, C.

المصدر: Paz-Ares , L , Spira , A , Raben , D , Planchard , D , Cho , B C , Özgüroğlu , M , Daniel , D , Villegas , A , Vicente , D , Hui , R , Murakami , S , Spigel , D , Senan , S , Langer , C J , Perez , B A , Boothman , A M , Broadhurst , H , Wadsworth , C , Dennis , P A , Antonia , S J & Faivre-Finn , C 2020 , ' Outcomes with durvalumab by tumour PD-L1 expression ....

مصطلحات موضوعية: durvalumab, immunotherapy, non-small-cell lung cancer, PACIFIC, PD-L1 expression, stage III

الإتاحة: https://doi.org/10.1016Test/j.annonc.2020.03.287
https://research.manchester.ac.uk/en/publications/a5aec273-8cc5-490b-a998-902a4c784ffcTest
http://www.scopus.com/inward/record.url?scp=85084203905&partnerID=8YFLogxKTest

المؤلفون: Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C. J., Raben, D., Perez, B., Özgüroğlu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Paz-Ares, L., Poole, L., Wadsworth, C., Dennis, P. A., Antonia, S. J.

المصدر: Faivre-Finn , C , Spigel , D R , Senan , S , Langer , C J , Raben , D , Perez , B , Özgüroğlu , M , Daniel , D , Villegas , A , Vicente , D , Hui , R , Murakami , S , Paz-Ares , L , Poole , L , Wadsworth , C , Dennis , P A & Antonia , S J 2018 , ' Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC ' , Annals of ....

العلاقة: https://research.vumc.nl/en/publications/63ef2a26-6c13-4c15-ac40-81eb78c7df93Test

الإتاحة: https://doi.org/10.1093/annonc/mdy291Test
https://research.vumc.nl/en/publications/63ef2a26-6c13-4c15-ac40-81eb78c7df93Test
http://www.scopus.com/inward/record.url?scp=85081531617&partnerID=8YFLogxKTest

المؤلفون: Bonomi, P D, Gandara, D, Hirsch, F R, Kerr, K M, Obasaju, C, Paz Ares, Luis Gonzaga, Bellomo, C, Bradley, J D, Bunn, P A, Culligan, M, Jett, J R, Kim, E S, Langer, C J, Natale, R B, Novello, S, Pérol, M, Ramalingam, S S, Reck, M, Reynolds, C H, Smit, E F, Socinski, M A, Spigel, D R, Vansteenkiste, J F, Wakelee, H, Thatcher, N

المساهمون: Fundación Lilly

مصطلحات موضوعية: GROWTH-FACTOR RECEPTOR, PHASE-III TRIAL, CLINICAL-PRACTICE GUIDELINES, CISPLATIN PLUS GEMCITABINE, OPEN-LABEL, STAGE IV, 1ST-LINE THERAPY, FOLLOW-UP, CETUXIMAB, CHEMOTHERAPY

العلاقة: https://doi.org/10.1093/annonc/mdy196Test.; Ann Oncol. 2018; 29(8):1701-1709.; http://hdl.handle.net/20.500.12105/6820Test; Annals of oncology : official journal of the European Society for Medical Oncology

الإتاحة: https://doi.org/20.500.12105/6820Test
https://doi.org/10.1093/annonc/mdy196Test
https://hdl.handle.net/20.500.12105/6820Test

المؤلفون: Langer, C J, Hirsh, V, Okamoto, I, Lin, F-J, Wan, Y, Whiting, S, Ong, T J, Renschler, M F, Botteman, M F

المصدر: British Journal of Cancer ; volume 113, issue 1, page 20-29 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2015.181Test
http://www.nature.com/articles/bjc2015181.pdfTest
http://www.nature.com/articles/bjc2015181Test

المؤلفون: Villegas, A., Paz-Ares, L., Spira, A., Raben, D., Planchard, D., Cho, B. C., ÖZGÜROĞLU, Mustafa, Daniel, D., Vicente, D., Hui, R., Murakami, S., Spigel, D., Senan, S., Langer, C. J., Perez, B. A., Boothman, A-M, Broadhurst, H., Wadsworth, C., Dennis, P. A., Antonia, S. J., Faivre-Finn, C.

المساهمون: CIBER - Centro de Investigacion Biomedica en Red ,, 2283195

مصطلحات موضوعية: İç Hastalıkları, ONKOLOJİ, Klinik Tıp, Klinik Tıp (MED), Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, Onkoloji

العلاقة: ANNALS OF ONCOLOGY; Paz-Ares L., Spira A., Raben D., Planchard D., Cho B. C. , ÖZGÜROĞLU M., Daniel D., Villegas A., Vicente D., Hui R., et al., "Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial", ANNALS OF ONCOLOGY, cilt.31, ss.798-806, 2020; av_f5b6a60c-319f-4791-ab82-aef9bb9c76ef; vv_1032021; http://hdl.handle.net/20.500.12627/161034Test; https://doi.org/10.1016Test/j.annonc.2020.03.287; 31; 798; 806

الإتاحة: https://doi.org/20.500.12627/161034Test
https://doi.org/10.1016Test/j.annonc.2020.03.287
https://hdl.handle.net/20.500.12627/161034Test

المؤلفون: Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., Renschler, M. F.

مصطلحات موضوعية: lung cancer

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/24/2/314Test; http://dx.doi.org/10.1093/annonc/mds461Test

الإتاحة: https://doi.org/10.1093/annonc/mds461Test
http://annonc.oxfordjournals.org/cgi/content/short/24/2/314Test

المؤلفون: Gualberto A., Hixon M. L., Karp D. D., LI BASSI, DANIELE, Green S., Dolled-Filhart M., Paz-Ares L. G., Novello S., Blakely J., Langer C. J., Pollak M. N.

المساهمون: Gualberto, A., Hixon, M.L., Karp, D.D., Li, D., Green, S., Dolled-Filhart, M., Paz-Ares, L.G., Novello, S., Blakely, J., Langer, C.J., Pollak, M.N.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23211971; info:eu-repo/semantics/altIdentifier/wos/WOS:000312495300016; volume:107; issue:12; firstpage:2024; lastpage:2024; numberofpages:1; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/2318/1675628Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84870792537

الإتاحة: https://doi.org/10.1038/bjc.2012.497Test
http://hdl.handle.net/2318/1675628Test

المؤلفون: Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V, Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., Renschler, M. F.

مصطلحات موضوعية: Original article

وصف الملف: text/html

العلاقة: http://annonc.oxfordjournals.org/cgi/content/short/mds461v1Test; http://dx.doi.org/10.1093/annonc/mds461Test

الإتاحة: https://doi.org/10.1093/annonc/mds461Test
http://annonc.oxfordjournals.org/cgi/content/short/mds461v1Test

المؤلفون: Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N

المصدر: British Journal of Cancer ; volume 107, issue 12, page 2024-2024 ; ISSN 0007-0920 1532-1827

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1038/bjc.2012.497Test
http://www.nature.com/articles/bjc2012497.pdfTest
http://www.nature.com/articles/bjc2012497Test